The Putative Role of the Antiageing Protein Klotho in Cardiovascular and Renal Disease

DOI PDF XML 2 Citations
  • Giuseppe Maltese
    Cardiovascular Division, King's College London, 3rd Floor Franklin-Wilkins Building, Waterloo Campus, Stamford Street, London SE1 9NH, UK
  • Janaka Karalliedde
    Cardiovascular Division, King's College London, 3rd Floor Franklin-Wilkins Building, Waterloo Campus, Stamford Street, London SE1 9NH, UK

Abstract

<jats:p>Ageing is a multifactorial process often characterized by a progressive decline in physiological function(s). Ageing can and is often associated with an increased incidence of cardiovascular and renal disease. Klotho is a novel antiageing gene that encodes a protein with multiple pleiotropic functions including an emerging role in cardiorenal disease. Mice deficient for this gene display a phenotype of premature human ageing characterized by diffuse vascular calcification, altered calcium/phosphate metabolism, and shortened lifespan. Klotho is mainly expressed in the renal tubules but it also exists as circulating soluble form detectable in the blood, with systemic effects. Reduction in soluble Klotho has been associated with renal disease, hyperphosphataemia, increased oxidative stress, endothelial dysfunction, and diffuse vascular calcification. Conversely, overexpression of Klotho promotes cardiovascular-renal protection. The majority of the research on Klotho has been conducted in vitro and in animal studies but there is emerging data from human studies which suggest that Klotho may be a modifiable factor involved in the pathogenesis of cardiovascular and renal disease in at-risk populations. Further data is required to confirm if this novel protein can emerge as therapeutic tool that may be used to prevent or slow progression of cardiorenal disease.</jats:p>

Journal

Citations (2)*help

See more

Report a problem

Back to top